News releases - Merck.com
WEB3 days ago · FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) September 17, 2024.
Merck Provides Update on FDA’s Oncologic Drugs Advisory …
WEB1 day ago · RAHWAY, N.J., Sept. 26, 2024 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the outcomes of today’s U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting. The meeting was convened to discuss the risk-benefit assessment of the use of immune checkpoint inhibitors, including KEYTRUDA® (pembrolizumab), […]
Merck wins first FDA approval for Keytruda as a treatment for ...
WEBSep 18, 2024 · Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated ...
FDA approves Merck's drug for rare, deadly lung condition
WEBMar 26, 2024 · The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients...
News & Stories - Merck
WEBSep 16, 2024 · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
Moderna and Merck Announce mRNA-4157/V940, an …
WEBDec 13, 2022 · This news release of Merck & Co., Inc., Rahway, N.J., USA (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of …
Merck to Present New Long-Term Data for Tulisokibart (MK-7240), …
WEB1 day ago · Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new data highlighting the long-term efficacy and safety ... N.J., USA This news release of Merck & Co ...
Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
WEBMar 26, 2024 · Merck MRK 0.53% is making a big bet that its new drug, approved Tuesday in the U.S. for a potentially fatal lung disease, will take the company a long way toward heading off a massive revenue ...
Merck Enters Two Strategic Collaborations to Strengthen AI-driven …
WEBSep 20, 2023 · Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts.
Merck Launches First Ever AI Solution to Integrate Drug Discovery …
WEBDec 5, 2023 · Merck, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule ...